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Abstract
Background:  Translating scientific evidence into daily practice is problematic. All kinds of
intervention strategies, using educational and/or directive strategies, aimed at modifying behavior,
have evolved, but have been found only partially successful. In this article the focus is on
(computerized) decision support systems (DSSs). DSSs intervene in physicians' daily routine, as
opposed to interventions that aim at influencing knowledge in order to change behavior. We
examined whether general practitioners (GPs) are prescribing in accordance with the advice given
by the DSS and whether there is less variation in prescription when the DSS is used.
Methods:  Data were used from the Second Dutch National Survey of General Practice
(DNSGP2), collected in 2001. A total of 82 diagnoses, 749811 contacts, 133 physicians, and 85
practices was included in the analyses. GPs using the DSS daily were compared to GPs who do not
use the DSS. Multilevel analyses were used to analyse the data. Two outcome measures were
chosen: whether prescription was in accordance with the advice of the DSS or not, and a measure
of concentration, the Herfindahl-Hirschman Index (HHI).
Results: GPs who use the DSS daily prescribe more according to the advice given in the DSS than
GPs who do not use the DSS. Contradictory to our expectation there was no significant difference
between the HHIs for both groups: variation in prescription was comparable.
Conclusion:  We studied the use of a DSS for drug prescribing in general practice in the
Netherlands. The DSS is based on guidelines developed by the Dutch College of General
Practitioners and implemented in the Electronic Medical Systems of the GPs. GPs using the DSS
more often prescribe in accordance with the advice given in the DSS compared to GPs not using
the DSS. This finding, however, did not mean that variation is lower; variation is the same for GPs
using and for GPs not using a DSS. Implications of the study are that DSSs can be used to implement
guidelines, but that it should not be expected that variation is limited.
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Background
According to Grol and Grimshaw [1]: "One of the most con-
sistent findings in research of health services is the gap between
evidence and practice. Results of studies in the USA and the
Netherlands suggest that about 30–40% of patients do not
receive care according to present scientific evidence, and about
20–25% of care provided is not needed or is potentially harm-
ful". These are causes of unwanted variations in health
service provision. Introducing evidence and clinical
guidelines into daily practice is problematic. All kinds of
intervention strategies, using educational and/or directive
strategies, aimed at modifying behavior, have been devel-
oped, but found only partially successful [e.g. [1-3]].
Although different treatments can be effective, and inno-
vations are not likely to occur when there is no variation,
the existence of variation will have an effect on the profes-
sion of medicine. Physicians will have to explain why
there is variation. Meaning that they will have to explain
why similar patients with the same diagnosis are treated
differently. Policy makers and third party payers will get
involved as they might be convinced that health care
expenses can be limited when all physicians choose the
most cost-effective treatment. Variation might give
patients a choice in the treatment they prefer, and it might
help in finding better treatments, but as long as there are
questions about the justifiability of variation physicians
will have to deal with it, limit or explain it, or otherwise
insurers or the government probably will.
This article focuses on computerized decision support sys-
tems (DSSs). The use of DSSs is a way to improve physi-
cians' performance [4]. Computerized systems rationalize
medical practice, by implementing evidence into medical
practice, and in doing so decrease variation in medical
practice [5,6]. They are meant to improve the capacity of
physicians to make better decisions whilst the complex
problems physicians deal with surpass their cognitive
capacity [5]. Computerized systems intervene in physi-
cians' daily routine, as opposed to interventions that aim
at influencing knowledge in order to change behavior.
Intervening in physicians' daily routine was found to be
effective in changing behavior for instance in blood test
ordering [7].
In the Netherlands a DSS for prescribing drugs was intro-
duced for general practitioners (GPs) in 1998. The DSS
was introduced to implement professional guidelines
regarding the prescription of drugs. Prescription of drugs
has great importance in modern health care; the develop-
ment of new and effective drugs has contributed to the
increase of the health status in the OECD countries [8]. In
modern health care, appropriate prescribing of new and
expensive drugs is a big challenge as the number of avail-
able drugs is increasing, making choice more complex.
Prescription of drugs is influenced by the pharmaceutical
industry [e.g. [9]], the professional environment [e.g. [2]],
physicians' and patients' habits [e.g. [10,11]]; all factors
that are not directly related to treatment outcome. Denig
[12] showed that physicians choose from a limited
evoked set of drugs which comes up in their minds, given
the health problem of the patient. This evoked set is influ-
enced by advertising, and (continuing) education. More
than 70% of drugs prescribed are drugs from the evoked
set [13]. This 70% is 'top of the mind' drugs, meaning
that, given the diagnosis, these drugs come to the mind
directly, based on habits. Physicians do not consider all
possible treatment options, but chose from approxi-
mately two to five different options [12]. In order to
change the drugs physicians prescribe, the evoked set of
physicians has to be changed, or its role in decision mak-
ing should be changed. The evoked set should become
less important or should even be avoided when a change
in prescribing behavior is necessary. That is where DSSs
come in. Instead of relying on the evoked set of drugs for
physicians to choose one in a specific situation, the DSS
proposes one or more drugs of preference, based on char-
acteristics of the patient and professional guidelines. The
introduction of DSSs is expected to result in more rational
prescribing and less unexplained and illegitimate varia-
tion in prescribing between physicians [12,14-16].
Educational interventions and giving feedback as meth-
ods to enhance evidence based practice rely on changing
the evoked set in the minds of physicians. DSSs, however,
directly affect physicians' routines. The strategy of chang-
ing physicians' routines has shown to be effective in for
instance blood test ordering. Zaat et al. [17] found that by
simply changing the application form, the amount of
unnecessary test ordering was drastically decreased. After
changing the form back into its original format the physi-
cians showed their old test ordering behavior.
DSSs can be useful tools in medical practice; they can
assist physicians in making evidence based decisions and
can therefore improve the quality of care. Quality of care
will only improve with the use of DSSs if the recommen-
dations are evidence based and the DSS is actually used as
intended. DSSs do therefore not always improve clinical
practice. Hunt et al. [18] showed in their systematic review
that most systems significantly improved clinical practice,
but some (34%) did not. Lobach and Hammond [19]
found in their study on clinical practice in the USA that
DSSs improved compliance with care standards. Shea et
al. [20] found evidence from a meta-analysis of rand-
omized controlled studies that supports the effectivenessBMC Health Services Research 2009, 9:20 http://www.biomedcentral.com/1472-6963/9/20
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of data-driven computer-based reminder systems to
improve prevention services in the ambulatory care set-
ting. Johnston et al. [21] concluded from their review that
recommendations from DSSs can improve compliance
with guidelines for preventive and acute care. Improve-
ment of guideline adherence was also shown by Shiffman
et al. [22] in their systematic review on the effectiveness of
computer-based guideline implementation systems. In a
systematic review on the effects of DSSs on physician per-
formance and patient outcomes it was concluded that
DSSs can enhance clinical performance for drug dosing,
preventive care, and other aspects of medical care, but not
convincingly for making the diagnosis [18]. Furthermore,
they concluded that the effects on patient outcomes have
been insufficiently studied. A study by Ramnarayan et al.
[23] suggests a promising role for DSSs in the reduction of
diagnostic error. DSSs result in improved clinical practice
if support is provided automatically as part of physicians'
workflow, support is delivered at the time and location of
decision making, actionable recommendations are pro-
vided and support is computer based [6].
DSSs can influence physicians' behavior and at the same
time influence variation in prescribing between physi-
cians. Generally, variation is reduced by shared normative
systems, rules and common frameworks of meaning [24].
That is, variation decreases when people adhere to the
same norms and rules, or make use of the same frame-
works of meaning. DSSs can be considered frameworks of
meaning, people do not have to be aware of what a DSS
does when they use it and DSSs do not work via behavio-
ral confirmation or sanctioning as norms and rules do. As
such they can decrease variation amongst those who make
use of the DSS.
In this article we will study a DSS which is used by GPs in
the Netherlands as a tool to give advice on prescription
when the diagnosis is given. The DSS proposes a prescrip-
tion, given the diagnosis of the patient, taking into
account age, sex and co-morbidity. As mentioned before,
four features are associated with the ability to improve
clinical practice, it is part of the workflow, support is
delivered at the time and location of decision making,
actionable recommendations are provided and it is com-
puter based [6]. The DSS for GPs in the Netherlands meets
these four features [25]. In the advice patient characteris-
tics, like age, sex, co-morbidities and other drugs pre-
scribed are taken into account. The DSS is integrated in
the Electronic Medical Systems (EMS) of the GPs. The
advice given is derived from professional-guidelines.
These guidelines are developed by the Dutch College of
General Practitioners (NHG) and are widely accepted
[26]. Wolters et al. [27] studied the use of the DSS by GPs
in the Netherlands. They found that having access to the
DSS increased from 20% in 1999 to 71% of GPs in 2001,
and daily use from 11% to 40%.
In this article we will examine the influence of computer-
ized decision support on prescribing by GPs in the Neth-
erlands. Two questions will be addressed.
1 'Do GPs who use the DSS on a regular basis prescribe more
often in accordance with the advice given by the DSS?'
2 'Is there less variation in prescription among GPs who use the
DSS on a regular basis compared to those who do not?'
Hypotheses
An effective method for changing physicians behavior, or
implementing new techniques, is to make them save time
if they change or comply [28]. An effective DSS minimizes
the effort required by physicians to receive and act on the
recommendations [6]. DSSs in the Netherlands give GPs
information at the time a decision has to be made. Thus,
GPs do not have to recall information from the mind, and
can more easily prescribe according to professional guide-
lines, even without having to make a conscious choice. It
is expected that those who use the DSS, prescribe according to
the guidelines that are incorporated in the DSS.
The more GPs use the DSS, the more their prescriptions
will be in accordance with the advice given in the DSS. If
GPs use the DSS there will be less variation in prescrip-
tion. It is expected that there is less variation in prescribing
between GPs using the DSS compared to GPs not using the
DSS.
Methods
Data
Data were used from the Second Dutch National Survey of
General Practice (DNSGP2), collected in 2001. Data were
collected on contacts, patients, GPs and practices. For a
description of the data-collection we refer to Westert et al.
[29]. DNSGP2 is used for many different research ques-
tions and analyses. The basis of DNSGP2 was an extrac-
tion of the electronic medical records from 103 general
practices during one year. The electronic medical records
contained the Anatomical Therapeutic Chemical (ATC)-
coded prescription data [30]. DSS use was assessed
through a questionnaire filled in by 191 GPs working in
the 103 practices in March 2001, 188 questionnaires
could be used. The response was 96%. In the question-
naire it was asked if the GPs had a DSS and how many
times the DSS was used. The questionnaire was not
designed for this specific article and consequently the GPs
were not aware of this study. The current study is a second-
ary analysis of the DNSGP2 data base. The total DNSGP2
population can be found in Table 1[31]. The study was
carried out in keeping with Dutch legislation on privacy.
Compliance with privacy regulations was approved by the
Dutch Data Protection Authority. According to Dutch leg-
islation, neither obtaining informed consent nor approvalBMC Health Services Research 2009, 9:20 http://www.biomedcentral.com/1472-6963/9/20
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by a medical ethics committee was obligatory for this
study
Method
The DSS includes an advice for 172 diagnoses. These diag-
noses were included in our analyses if in at least 1,250
contacts a prescription was given for this diagnosis. A
minimum was set to exclude diagnoses that hardly appear
in GPs practices. The minimum was set at 1,250 contacts
for computational restrictions. A total of 82 diagnoses
were included in the analyses. Contacts were included
only if type of medicine (ATC-5) and diagnosis (ICPC
coded) were known. All participating GPs have had a cod-
ing training at inclusion in DNSGP2. Because of missing
diagnoses sixteen practices were excluded. A description
of the GPs in our analysis compared to the total DNSGP2
study group as well as to the total population in the Neth-
erlands can be found in Table 1. There is an overrepresen-
Table 1: Selection of GPs used in this article, the study population of DNSGP2 and the total population of Dutch GPs at the time of 
data collection.
GPs included in this article from DNSGP2 (%) Study population DNSGP2 (%) Total GP population in the Netherlands in 2001 (%)
Sex:
Male 78 73 74
Female 22 27 26
Age:
<35 1 4 6
35–39 15 15 15
40–44 15 18 20
45–49 32 30 25
50–54 25 25 22
55–59 12 8 10
60+ 1 1 2
Type of practice:
Single handed 51 31 43
Shared 24 28 33
Group/Health centre 26 42 25
Table 2: Description of included data (absolute numbers)
Included data* DSS daily users DSS non users/owners
Number of practices 85 29 33
Number of physicians 133 44 43
Number of patients 749811 251587 242786
Number of diagnoses 82 82 82
Type of practice:
Group 22 10 9
Dispensing (pharmacy included) 9 3 1
Dispensing (with pharmacy) 1 0 0
Not dispensing (no pharmacy) 73 26 32
Missing 20 0
TOTAL 85 29 33
EMS:
Microhis 23 5 16
Promedico 29 14 5
Elias 22 7 10
Arcos 11 3 2
TOTAL 85 29 33
Number of physicians per practice (mean (st.dev) [range]) 1.6 (1.1) [1–5] 1.5 (1.1) [1–5] 1.3 (0.7) [1–4] 
Number of different drugs per diagnosis in DSS (mean (st.dev) [range] 4.0 (2.4) [1–11] 4.0 (2.4) [1–11] 4.0 (2.4) [1–11]
Number of different drugs prescribed per physician per diagnosis 
(mean (st.dev) [range])
7.0 (6.7) [1–156] 6.7 (6.1) [1–66] 7.2 (6.9) [1–77]
*selected based on whether diagnoses are in the DSSBMC Health Services Research 2009, 9:20 http://www.biomedcentral.com/1472-6963/9/20
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tation of single handed practices in our population. A
total of 749,811 contacts, 133 physicians, and 85 practices
were thus included in the analyses (Table 2).
For this study two extremes were created: those GPs who
use the DSS daily and those GPs who do not use the DSS
at all. The latter group both includes GPs who do not have
a DSS and GPs who do have a DSS but do not use it. An
important difference between both groups is in the Elec-
tronic Medical System they use. We have controlled for
this difference in the analyses.
Specifics in the methods differ between the two questions
addressed in this article. Therefore, the specific methods
will be described for each question separately.
Are GPs prescribing in accordance with the advice given by the 
information system?
Dependent variable
As dependent variable a measure was used that indicated
whether a prescription was in accordance with DSS or not.
For each diagnosis (ICPC coded) a list of prescriptions
(ATC-5 coded) advised in the DSS was used [25]. These
proposed prescriptions were compared with the actual
prescriptions for patients. If prescriptions for patients
were similar to the prescription in the list it was in accord-
ance with the DSS, if it was different it was not in accord-
ance with the DSS. The comparison was done for both
GPs using the DSS and for GPs not using the DSS.
Model
Multilevel analyses were used to take into account the
structure of the data: contacts are nested within GPs and
GPs are nested within practices [32-34]. The model there-
fore consists of three levels; the contact, the GP and the
practice level. Because the dependent variable was dichot-
omous, a multilevel logistic regression was performed
(see appendix 1 for the full model). The percentage of
contacts in which patients receive prescriptions in accord-
ance with the DSS was computed, taking the diagnosis
into account and correcting for the specific EMS, practice
type, and the number of GPs in a practice. Besides, a vari-
able was included indicating whether or not a practice was
dispensing for all or part of the population. The variable
was included because medication prescribed by medical
specialists was also included in the data collection for GPs
in a dispensing practice, but are not recognized as such.
Hence, in these practices part of the prescribing decisions
might have been made by medical specialists. For the
model to have interpretable meaning, variables were cen-
tered around their means. Diagnoses were not only
included in the fixed part of the model, but also in the ran-
dom part of the model. The latter was done because the
observations are not independent; different physicians
face patients with the same diagnoses and hence the same
advice of the DSS which has an effect on what is pre-
scribed.
Is there less variation in prescription when the information system is 
used?
Dependent variable
As dependent variable to measure variation in prescribing
a measure of concentration was used, the Herfindahl-Hir-
schman Index (HHI) [35,36]. This measure was based on
whether the prescriptions for a given diagnosis were dis-
tributed over a large number of different drugs or only one
or a few drugs. The kind of drug was identified based on
the ATC-5 code. The HHI was measured as Σ(a/b)2; where
a is the number of times a specific drug was prescribed per
diagnosis per GP and b is the total number of times any
drug is prescribed for this diagnosis per GP. The HHI was
measured for each drug prescribed per diagnosis per GP
and these values were summed for all drugs prescribed per
diagnosis per GP. The range of this index goes from a low
point of 1 divided by the number of drugs prescribed per
diagnosis to a maximum of 1. A low index means that all
drugs are equally often prescribed while 1 means that
there is only one drug prescribed. The higher the concen-
tration the less variation in drug prescription there is. The
HHI was multiplied by 100 for ease of interpretation of
the coefficients.
In contrast to the previous model, the HHI, the concentra-
tion index, is not a characteristic of a single patient contact
but of the aggregate of patient contacts with the same
diagnosis. It is measured per diagnosis per GP.
Model
The data are hierarchically structured and therefore multi-
level models are the appropriate statistical approach [32-
34]. The model consists of three levels; diagnoses, GPs
and practices. Since different GPs face patients with simi-
lar diagnoses, again a model, which allows for depend-
ence between observations, was chosen (see appendix 2
for the full model).
To account for differences in patient population between
GPs the mean age and sex of the patient population of a
GP were initially included. These variables did only have
a small effect and were excluded from the final analyses.
Corrections were made for the different diagnoses by
including all diagnoses in the random part of the model.
They were, as opposed to the previous analysis, not
included in the fixed model because the HHI was meas-
ured per diagnosis. As mentioned before, the HHI was
measured per GP per diagnosis and therefore each diagno-
sis occurred only once for each GP. Furthermore, the spe-
cific EMS, practice type, the number of GPs in a practice,
and the number of different drugs suggested in the DSS
per diagnosis were included. A variable was included indi-BMC Health Services Research 2009, 9:20 http://www.biomedcentral.com/1472-6963/9/20
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cating whether or not a practice was dispensing for all or
part of the population. As in the previous model, all vari-
ables were centered to give the model interpretable mean-
ing.
Results
Are GPs prescribing in accordance with the advice given by 
the information system?
In line with our expectation GPs who use the DSS daily
prescribe more according to the advice given in the DSS
than GPs who do not use the DSS (Table 3). Still, prescrip-
tion by GPs who do not use the DSS is in line with advices
given in the DSS in 75% of all prescriptions, against 89%
for daily users. In appendix 3 the total model is presented.
The fixed effects show that there are differences between
diagnoses in whether GPs prescribe in accordance with
the advice given in the DSS.
Is there less variation in prescription when the information 
system is used?
Contradictory to our expectation there is no significant
difference between the HHIs, the indicator we used to
measure variation, for GPs using the DSS daily and GPs
who do not own or use the DSS (Table 4). Apparently the
variation in prescription is comparable for both groups. In
appendix 4 the total model is presented. The fixed part of
the model shows a relatively strong effect of the number
of different drugs advised in the DSS. If this number is
larger there is more variation in prescribing. From the ran-
dom part we learn that the HHI shows differences
between diagnoses. Comparing groups of diagnoses, vari-
ation in HHI is relatively low in diagnoses related to the
skin and relatively high in the diagnoses from the chapter
'general' of the ICPC, the first five diagnoses of the list.
Discussion
GPs using a DSS are prescribing in accordance with the
advice given in the DSS more than GPs not using a DSS.
Still, variation is the same for GPs using a DSS and for GPs
not using a DSS.
The DSS for prescribing by GPs in the Netherlands incor-
porates the professional guidelines of the Dutch College
of General Practitioners. Therefore, the DSS can be seen as
a way to implement guidelines. Guidelines and their
incorporation in a DSS are part of a general trend towards
rationalization of medicine in the Western world and one
of the general implications of rationalization processes is
a decrease in variation. The use of DSSs was hypothesized
to decrease variation between physicians, because physi-
cians who use a DSS that is based on the same profes-
sional guidelines make use of the same cognitive
framework.
Although GPs are using the DSS and thus the same cogni-
tive framework, variation did not decrease. How can we
explain this finding? DSSs give recommendations for pre-
scribing certain drugs. The DSS for prescribing by GPs that
we studied advises several different drugs or recommends
a stepwise treatment starting with one type of drug and
changing that type of drug later on when necessary. We
were not able to take stepwise use of different drugs into
account in our definition of conformity to the advice of
the DSS. As a consequence, variation can be generated.
GPs not using the DSS prescribe from their evoked set and
probably do not use a stepwise treatment strategy.
Although variation does not necessarily mean that some
patients receive bad quality of care, it does raise questions
related to effectiveness, efficiency and equity [37]. Evi-
dence on medical practice variations implicates that there
might be inappropriate servicing, waste of resources and
maybe even harm to patients [38].
In the Netherlands the advice given in the DSS is derived
from professional guidelines, developed by the Dutch
College of General Practice. The formularies correspond
to the NHG-guidelines for 65–70% [14]. The NHG-guide-
lines both reflect what is common in the profession and
what should become common [39,40]. Only part of the
NHG-guidelines published between 1989 and 2000 are
evidence-based. They are mostly based on consensus
between members of the study groups that are involved in
the development of the guidelines [41]. Of 130 recom-
mendations in 28 NHG-guidelines published between
1993 and 1997, 44% was evidence-based [42]. Scientific
evidence is developing continuously and guidelines
should therefore be changed according to the latest evi-
dence on a regular basis. GPs can be ahead of changes in
the guideline and already use new evidence before the
guideline is updated [43]. Guidelines reflecting common
practice, and GPs being ahead of guidelines can explain
that GPs not using the DSS prescribe in accordance with
the advice. The fact that we did not find a difference in var-
Table 3: Proportion of prescriptions in accordance with DSS, corrected for EMS, type of practice, dispensing practice, number of GPs 
in a practice (full model in appendix 3)
in accordance with DSS (st. error) Difference
DSS daily users 0.89 (0.06)
DSS non users/havers 0.75 (0.05) 0.14 (p = 0.04)BMC Health Services Research 2009, 9:20 http://www.biomedcentral.com/1472-6963/9/20
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iation between daily users and non-users of the DSS indi-
cates that the introduction of the DSS did not lead to
simple cookbook medicine.
This article does not question whether or not the profes-
sional guidelines, incorporated in the DSS, are adequate
and whether or not prescribing quality is better for the
users of the DSS. These are different questions from the
one discussed in this paper and would require a guideline
by guideline analysis of evidence and data. In our article
we only tested whether or not over a large domain of diag-
noses, there is indeed more conformity to the advice of
the DSS among daily users than among non-users.
One of the limitations of this study is that we do not know
whether there has been a change in the behavior of GPs
when they started using the DSS. GPs using the DSS were
compared to GPs not using the DSS in the same time
period. We could not perform a longitudinal analysis
which would make it possible to detect a change in behav-
ior. From the analysis performed, we conclude that GPs
using the DSS prescribe according to it and thus comply
with professional guidelines more than GPs not using the
DSS. It is assumed that GPs change their prescribing
behavior when they start using the DSS, but it is possible
that they already did prescribe in accordance with the
advice. Another limitation is that coding the diagnosis is
a condition to use the DSS. We used only data from prac-
tices coding the diagnoses in the ICPC-system. We needed
these codes to be able to construct our dependent variable
that indicates conformity to the advice, given by the DSS.
It is possible that the non-users of the DSS that neverthe-
less use the ICPC-coding in their EMR are a positive selec-
tion.
We assume that the coded diagnosis reflects what GPs
think is the diagnosis at the time they enter its code in the
system. It is this diagnosis that steers their prescription
decision, irrespective of whether or not this diagnosis was
correct or incorrect.
Although the questions answered in this article are fairly
simple, the analyses were complicated. For both questions
it was necessary to take the diagnoses into account. Fur-
thermore, variation in prescription is not measured easily.
To overcome the first difficulty, we could have chosen to
examine specific diagnoses. Analyzing every diagnosis
separately and aggregating the results over all diagnoses
would ignore the fact that physicians' prescribing deci-
sions in one diagnosis are correlated to the same physi-
cians' prescribing decisions in another diagnosis.
Moreover, our model structure takes into account the fact
that prescribing decisions of different physicians for the
same diagnosis will be correlated as well. Moreover, we
were testing a general hypothesis and having separate out-
comes for each (group of) diagnosis would ignore the cor-
relation of prescribing decisions. To take the specific
diagnoses into account and the fact that the same diagno-
sis is encountered by different GPs, we used a model, tak-
ing into account that the same diagnosis can 'belong' to
different GPs. The statistical model we developed has the
additional advantage that it is able to identify (groups of)
diagnoses with relatively low and high conformity to the
DSS' advice, taking the data structure into account.
The second difficulty, how to measure variation in pre-
scription, had several possible solutions. Counting the
range, the number of different drugs prescribed, was one
possibility [44]. Disadvantage of the range, however, is its
insensitivity to the number of times a drug is prescribed.
For example, the range is two if both drugs are each ten
times prescribed, but also when one drug is ten times pre-
scribed and the other is prescribed a hundred times. Meas-
ures of concentration are sensitive for the number of times
a drug is prescribed. Therefore, the Herfindahl-Hirschman
Index (HHI), which is a measure of concentration, was
used; the higher the HHI the less different drugs are pre-
scribed.
This study implicates that physicians decision making
regarding prescription can be influenced with computer-
ized decision aids. Although we only studied the effect of
the DSS for drug prescribing in general practice in the
Netherlands, the result we found is in line with the results
of international reviews. To improve the quality of pre-
scribing these systems should be up-to-date and the
advice should be evidence based. However, the regular use
of a DSS did not result in lower practice variation.
Conclusion
This study demonstrates that GPs using a DSS are prescrib-
ing in accordance with the advice given in the DSS more
than GPs not using a DSS. This implicates that compliance
with guidelines improves when the DSS is used. This find-
ing, however, did not mean that variation is lower; varia-
tion is the same for GPs using and for GPs not using a
DSS. Implications of the study are that DSSs can be used
to implement guidelines, but that it should not be
expected that variation is limited. As DSSs can influence
prescription, it is important to make explicit who is devel-
oping the DSS and for what reason.
Table 4: Variation in prescribing, as measured by HHI, corrected 
for EMS, type of practice, dispensing practice, number of GPs in 
a practice, number of different drugs advised in the DSS (full 
model in appendix 4)
HHI (st. error) Difference
DSS daily users 40.3 (1.2)
DSS non users/havers 41.4 (1.3) 1.1 (p = 0.3)BMC Health Services Research 2009, 9:20 http://www.biomedcentral.com/1472-6963/9/20
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Appendix 1: The multilevel logistic model
γijk~ Binomial(nijk, πijk)
logit (πijk) = β0jkx0jk + β1jkx1jk + β2x2k + β3x3k + β4x4k + β5x5k 
+ β6x6k + β7x7k + β8x8k + β9x9k + β10x10ijk + ..... + β90x90ijk + 
e91ix91ijk + ...... + e172ix172ijk
β0jk = β0 + v0k + u0jk
β1jk = β1 + v1k + u1jk
γijk = dependent variable (conform DSS or not, dichoto-
mous)
i = 'patient populations' (an identifier for each diagnosis
per physician)
j = physicians
k = practices
β0jk = mean propotion conform DSS, per physician (daily
users)
β1jk = mean proportion conform DSS, per physician (non
users/havers)
x2 = EMR1, per practice (centred)
x3 = EMR2, per practice (centred)
x4 = EMR3, per practice (centred)
x5 = Duo practice, per practice (centred)
x6 = Group practice, per practice (centred)
x7 = Health centre, per practice (centred)
x8 = Dispensing practice, per practice (centred)
x9 = number of GPs, per practice (centred)
x10 ..........x90 = diagnosis (centred)
x91 ..........x172 = diagnosis
v = level -three variance (practice level)
u = level -two variance (physician level)
e = measurement error per diagnosis
Appendix 2: The multilevel model
γijk~ N(XB,Ω)
γijk = β0jkx0jk + β1jkx1jk + β2x2k + β3x3k + β4x4k + β5x5k + β6x6k + 
β7x7k + β8x8k + β9x9k + β10ix10ijk + ..... + e91ix91ijk
β0jk = β0 + v0k + u0jk
β1jk = β1 + v1k + u1jk
γijk = dependent variable (HHI, per diagnosis per physi-
cian)
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i = 'patient populations' (an identifier for each diagnosis
per physician)
j = physicians
k = practices
β0jk = mean HHI and variance parameters, per physician
(daily users)
β1jk = mean HHI and variance parameters, per physician
(non users/havers)
x2 = EMR1, per practice (centred)
x3 = EMR2, per practice (centred)
x4 = EMR3, per practice (centred)
x5 = Duo practice, per practice (centred)
x6 = Group practice, per practice (centred)
x7 = Health centre, per practice (centred)
x8 = Dispensing practice, per practice (centred)
x9 = number of GPs, per practice (centred)
x10 ..........x91 = diagnosis
v = level -three variance (practice level)
u = level -two variance (physician level)
e = measurement error per diagnosis
Appendix 3 Proportion of prescriptions in accordance
with DSS
Fixed effects   Estimate (st. error)
DSS use:
DSS daily users   0.89 (0.06)
DSS non users/havers   0.75 (0.05)
EMR:
EMR1 (centered)   0.42 (0.13)
EMR2 (centered)   0.28 (0.12)
EMR3 (centered)   0.14 (0.13)
Type of practice:
Duo practice (centered)   -0.13 (0.10)
Group practice (centered)   0.02 (0.17)
Health centre (centered)   -0.06 (0.22)
Dispensing practice (centered)   -0.27 (0.16)
Number of GPs (centered)   0.05 (0.05)
Diagnoses:
Allergy/allergic reaction nos (centered)   -0.21 (0.06)
No disease (centered)   -5.51 (0.36)
Iron deficiency anemia (centered)   1.21 (0.07)
Pernicious/folate deficiency anemia (centered)   -2.54
(0.10)
Stomach ache/stomach pain (centered)   1.37 (0.06)
Heartburn (centered)   1.40 (0.06)
Nausea (centered)   0.20 (0.07)
Diarrhea (centered)   -0.39 (0.07)
Constipation (centered)   0.60 (0.05)
Other presumed infections of digestive system (centered)
 -2.07 (0.10)
Disease of esophagus (centered)   1.76 (0.06)
Disorders of stomach function/gastritis (centered)   1.43
(0.06)
Irritable bowel syndrome (centered)   -0.91 (0.05)
Anal fissure/perianal abscess (centered)   -2.24 (0.10)
Abnormal sensations of eye (centered)   0.27 (0.06)
Infectious conjunctivitis (centered)   1.07 (0.06)
Allergic conjunctivitis (centered)   0.05 (0.06)
Otitis externa (centered)   0.61 (0.05)
Acute otitis media/myringitis (centered)   0.35 (0.05)BMC Health Services Research 2009, 9:20 http://www.biomedcentral.com/1472-6963/9/20
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Vertiginous syndrome/labyrinthitis/vestibulitis (cen-
tered)   0.82 (0.07)
Angina pectoris (centered)   0.55 (0.05)
Heart failure (centered)   -0.11 (0.05)
Uncomplicated hypertension (centered)   0.20 (0.04)
Hypertension with involvement target organs (centered)
 -0.31 (0.05)
Transient cerebral ischemia (centered)   1.10 (0.07)
Hemorrhoids (centered)   -0.50 (0.06)
Rheumatoid arthritis and allied conditions (centered)   -
0.43 (0.05)
Osteoarthritis of hip (centered)   -0.12 (0.07)
Osteoarthritis of knee (centered)   -0.19 (0.06)
Other osteoarthritis and allied conditions (centered)   -
0.25 (0.07)
Osteoporosis (centered)   -0.48 (0.06)
Headache (centered)   -0.10 (0.05)
Tension headache (centered)   0.09 (0.07)
Restless legs syndrome (centered)   -1.90 (0.08)
Vertigo/dizziness (centered)   0.23 (0.06)
Parkinsonism/paralysis agitans (centered)   0.11 (0.08)
Epilepsy, all types (centered)   -3.38 (0.10)
Migraine (centered)   1.81 (0.06)
Disturbances of sleep/insomnia (centered)   1.53 (0.04)
Affective psychosis (centered)   -2.27 (0.11)
Anxiety disorder/anxiety state (centered)   0.81 (0.05)
Depressive disorder/anxiety/depression (centered)   0.42
(0.04)
Cough (centered)   -0.84 (0.04)
Sympt/complt sinus (incl. Pain) (centered)   -2.77 (0.12)
U.R.I. (head cold)/rhinitis nos (centered)   -1.80 (0.05)
Sinusitis acute/chronic (centered)   -0.38 (0.04)
Tonsillitis acute (centered)   0.52 (0.06)
Acute laryngitis/tracheitis/croup (centered)   -2.48 (0.11)
Acute bronchitis/bronchiolitis (centered)   -4.06 (0.07)
Pneumonia (centered)   -0.88 (0.06)
Chronic bronchitis/bronchiectasis (centered)   0.52
(0.06)
Emphysema/chronic obstructive pulmonary disease (cen-
tered)   0.76 (0.04)
Asthma (centered)   0.89 (0.04)
Hayfever, allergic rhinitis (centered)   0.66 (0.04)
Localised redness/erythema/rash of skin (centered)   -
3.72 (0.17)
Herpes zoster (centert)   -0.13 (0.08)
Dermatophytosis (centered)   1.29 (0.05)
Moniliasis/monilia infection/candidiasis (centered)   -
2.22 (0.07)
Other infectious skin dis.nec/erysipelas (centered)   -
0.26 (0.06)
Impetigo (centered)   0.59 (0.07)
Seborrhoic dermatitis/other erythematous dermatoses
(centered)   -0.64 (0.05)
Atopic dermatitis/eczema (centered)   0.85 (0.05)
Contact dermatitis/skin allergy (centered)   0.28 (0.04)
Psoriasis w/wo arthropathy (centered)   0.39 (0.06)
Acne (centered)   1.95 (0.07)
Urticaria (centered)   -1.03 (0.06)
Other disease skin/subcutaneous tissue (centered)   -
1.77 (0.07)
Hyperthyroidism/thyrotoxicosis (centered)   0.76 (0.08)BMC Health Services Research 2009, 9:20 http://www.biomedcentral.com/1472-6963/9/20
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Hypothyroidism/myxedema (centered)   2.06 (0.07)
Diabetes mellitus (centered)   0.40 (0.04)
Gout (centered)   1.21 (0.07)
Lipid metabolism disorder (centered)   1.35 (0.05)
Cystitis/other urinary infect. Non-venereal (centered)
0.68 (0.04)
Family planning/oral contraceptive (centered)   0.33
(0.04)
Menstrual pain (centered)   1.25 (0.09)
Menstruation excessive (centered)   0.78 (0.08)
Menstruation irregular/frequent (centered)   0.74 (0.09)
Menopausal sympt./complt. (centered)   -0.33 (0.05)
Urogenital candidiasis, thrush (proven/unproven) (cen-
tered)   -0.30 (0.05)
Vaginitis/vulvitis, non venereal nos (centered)   -0.77
(0.07)
Benign prostatic hypertrophy (centered)   0.48 (0.08)
Random effects   Variance (st. error)
Practice level:
DSS daily users   0.00 (0.00)
DSS non users/havers   0.03 (0.02)
GP level:
DSS daily users   0.11 (0.02)
DSS non users/havers   0.04 (0.02)
Diagnosis level:
Pain: generalised/unspecified   0.99 (0.03)
Allergy/allergic reaction nos   1.03 (0.03)
No disease   1.00 (0.05)
Iron deficiency anemia   0.95 (0.03)
Pernicious/folate deficiency anemia   0.92 (0.04)
Stomach ache/stomach pain   0.96 (0.02)
Heartburn   0.95 (0.02)
Nausea   1.11 (0.04)
Diarrhea   0.98 (0.04)
Constipation   0.99 (0.01)
Other presumed infections of digestive system   1.02
(0.05)
Disease of esophagus   0.91 (0.02)
Disorders of stomach function/gastritis   0.97 (0.02)
Irritable bowel syndrome   1.02 (0.02)
Anal fissure/perianal abscess   1.03 (0.05)
Abnormal sensations of eye   0.92 (0.03)
Infectious conjunctivitis   1.03 (0.02)
Allergic conjunctivitis   0.97 (0.03)
Otitis externa   0.97 (0.02)
Acute otitis media/myringitis   1.03 (0.02)
Vertiginous syndrome/labyrinthitis/vestibulitis   0.94
(0.03)
Angina pectoris   1.00 (0.01)
Heart failure   1.03 (0.02)
Uncomplicated hypertension   0.98 (0.01)
Hypertension with involvement target organs   0.99
(0.02)
Transient cerebral ischemia   0.90 (0.03)
Hemorrhoids   1.02 (0.03)
Rheumatoid arthritis and allied conditions   1.03 (0.03)
Osteoarthritis of hip   0.96 (0.04)
Osteoarthritis of knee   1.00 (0.03)
Other osteoarthritis and allied conditions   1.01 (0.04)BMC Health Services Research 2009, 9:20 http://www.biomedcentral.com/1472-6963/9/20
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Osteoporosis   1.04 (0.03)
Headache   1.03 (0.02)
Tension headache   1.06 (0.04)
Restless legs syndrome   1.03 (0.04)
Vertigo/dizziness   0.97 (0.03)
Parkinsonism/paralysis agitans   1.02 (0.05)
Epilepsy, all types   1.06 (0.03)
Migraine   1.05 (0.02)
Disturbances of sleep/insomnia   0.97 (0.01)
Affective psychosis   1.12 (0.06)
Anxiety disorder/anxiety state   0.99 (0.02)
Depressive disorder/anxiety/depression   1.01 (0.01)
Cough   1.00 (0.01)
Sympt/complt sinus (incl. Pain)   1.08 (0.05)
U.R.I. (head cold)/rhinitis nos   1.00 (0.01)
Sinusitis acute/chronic   1.00 (0.01)
Tonsillitis acute   0.98 (0.03)
Acute laryngitis/tracheitis/croup   1.12 (0.05)
Acute bronchitis/bronchiolitis   1.18 (0.02)
Pneumonia   1.05 (0.03)
Chronic bronchitis/bronchiectasis   0.96 (0.02)
Emphysema/chronic obstructive pulmonary disease
1.01 (0.01)
Asthma   1.04  (0.01)
Hayfever, allergic rhinitis   1.01 (0.01)
Localised redness/erythema/rash of skin   1.11 (0.05)
Herpes zoster   1.03 (0.05)
Dermatophytosis   1.02 (0.01)
Moniliasis/monilia infection/candidiasis   1.05 (0.03)
Other infectious skin dis.nec/erysipelas   0.98 (0.03)
Impetigo   1.04 (0.03)
Seborrhoic dermatitis/other erythematous dermatoses
1.05 (0.02)
Atopic dermatitis/eczema   1.00 (0.02)
Contact dermatitis/skin allergy   0.99 (0.01)
Psoriasis w/wo arthropathy   1.04 (0.03)
Acne   1.05 (0.02)
Urticaria   1.05 (0.03)
Other disease skin/subcutaneous tissue   0.99 (0.04)
Hyperthyroidism/thyrotoxicosis   0.96 (0.04)
Hypothyroidism/myxedema   0.85 (0.02)
Diabetes mellitus   1.00 (0.01)
Gout   0.94 (0.03)
Lipid metabolism disorder   0.96 (0.01)
Cystitis/other urinary infect. Non-venereal   0.98 (0.01)
Family planning/oral contraceptive   1.03 (0.01)
Menstrual pain   0.98 (0.04)
Menstruation excessive   1.03 (0.04)
Menstruation irregular/frequent   1.05 (0.05)
Menopausal sympt./complt.   1.01 (0.02)
Urogenital candidiasis, thrush (proven/unproven)   1.03
(0.02)
Vaginitis/vulvitis, non venereal nos   1.03 (0.04)
Benign prostatic hypertrophy   1.00 (0.04)
Appendix 4 Total model used to measure the HHI
Fixed effects   Estimate (st. error)BMC Health Services Research 2009, 9:20 http://www.biomedcentral.com/1472-6963/9/20
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DSS use:
DSS daily users   40.3 (1.17)
DSS non users/havers   41.4 (1.27)
EMR:
EMR1 (centered)   -0.37 (2.99)
EMR2 (centered)   -2.06 (3.15)
EMR3 (centered)   -3.53 (3.09)
Type of practice:
Single handed practice (centered)   10.9 (5.14)
Duo practice (centered)   9.23 (4.37)
Group practice (centered)   5.43 (2.90)
Dispensing practice (centered)   2.04 (3.16)
Number of GPs (centered)   2.07 (1.24)
Number of different drugs advised in the DSS (centered)
 -3.37 (0.10)
Random effects   Variance (st. error)
Practice level:
DSS daily users   27.5 (9.35)
DSS non users/havers   0.00 (0.00)
GP level:
DSS daily users   3.48 (3.09)
DSS non users/havers   44.9 (10.9)
Diagnosis level:
Pain: generalized/unspecified   912.9 (153.8)
Allergy/allergic reaction nos   350.1 (55.69)
No disease   1,005 (206.3)
Iron deficiency anemia   1,500 (232.6)
Pernicious/folate deficiency anemia   1,302 (235.6)
Stomach ache/stomach pain   418.2 (65.43)
Heartburn   399.2 (62.86)
Nausea   979.8 (154.3)
Diarrhea   640 (102.4)
Constipation   233.3 (36.55)
Other presumed infections of digestive system   676.2
(112.6)
Disease of esophagus   804.6 (126)
Disorders of stomach function/gastritis   484.1 (76.6)
Irritable bowel syndrome   473.6 (74.17)
Anal fissure/perianal abscess   603.7 (102.1)
Abnormal sensations of eye   716.1 (114.9)
Infectious conjunctivitis   918.8 (140)
Allergic conjunctivitis   471.7 (73.22)
Otitis externa   470.5 (72.37)
Acute otitis media/myringitis   269.5 (42.23)
Vertiginous syndrome/labyrinthitis/vestibulitis   1125
(179.1)
Angina pectoris   402.9 (64.12)
Heart failure   273.9 (43.42)
Uncomplicated hypertension   398.7 (61.52)
Hypertension with involvement target organs   619.7
(100.6)
Transient cerebral ischemia   1,626 (269)
Hemorrhoids   438.1 (67.8)
Rheumatoid arthritis and allied conditions   543.6
(88.25)
Osteoarthritis of hip   942.2 (161)
Osteoarthritis of knee   315.7 (53.24)BMC Health Services Research 2009, 9:20 http://www.biomedcentral.com/1472-6963/9/20
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Other osteoarthritis and allied conditions   851.8
(146.7)
Osteoporosis   556.7 (91.72)
Headache   233.8 (36.95)
Tension headache   438.8 (71.34)
Restless legs syndrome   1,141 (194.2)
Vertigo/dizziness   818.8 (128.2)
Parkinsonism/paralysis agitans   1,484 (278.3)
Epilepsy, all types   702.5 (116.1)
Migraine   767.8 (118)
Disturbances of sleep/insomnia   304.8 (47.83)
Affective psychosis   1,131 (233.7)
Anxiety disorder/anxiety state   297.3 (47.08)
Depressive disorder/anxiety/depression   194.7 (30.77)
Cough   621.1 (95.94)
Sympt/complt sinus (incl. Pain)   1465 (282.6)
U.R.I. (head cold)/rhinitis nos   837.8 (128.9)
Sinusitis acute/chronic   99.38 (15.89)
Tonsillitis acute   572.7 (89.45)
Acute laryngitis/tracheitis/croup   1,103 (188.4)
Acute bronchitis/bronchiolitis   1,058 (162.9)
Pneumonia   495.7 (77.23)
Chronic bronchitis/bronchiectasis   527.5 (86.3)
Emphysema/chronic obstructive pulmonary disease
57.73 (9.49)
Asthma   69.96  (11.34)
Hayfever, allergic rhinitis   300 (46.59)
Localised redness/erythema/rash of skin   676.7 (107.1)
Herpes zoster   736.8 (118.6)
Dermatophytosis   197.5 (30.83)
Moniliasis/monilia infection/candidiasis   592.3 (94.62)
Other infectious skin dis.nec/erysipelas   302.6 (48.2)
Impetigo   682.8 (106.5)
Seborrhoic dermatitis/other erythematous dermatoses
488.4 (75.41)
Atopic dermatitis/eczema   188.8 (29.58)
Contact dermatitis/skin allergy   352 (54.49)
Psoriasis w/wo arthropathy   276.2 (43.5)
Acne   180.6 (28.32)
Urticaria   482.5 (74.82)
Other disease skin/subcutaneous tissue   633 (99.3)
Hyperthyroidism/thyrotoxicosis   1,067 (190.4)
Hypothyroidism/myxedema   1,731 (269.9)
Diabetes mellitus   304.3 (47.23)
Gout   384.1 (60.24)
Lipid metabolism disorder   1,051 (161.1)
Cystitis/other urinary infect. Non-venereal   130.7 (20.6)
Family planning/oral contraceptive   354.2 (54.62)
Menstrual pain   669 (111.2)
Menstruation excessive   864.6 (135.5)
Menstruation irregular/frequent   1,708 (272.2)
Menopausal sympt./complt.   243.3 (37.94)
Urogenital candidiasis, thrush (proven/unproven)
193.9 (30.39)
Vaginitis/vulvitis, non venereal nos   659.5 (106.3)
Benign prostatic hypertrophy   1,616 (267.3)BMC Health Services Research 2009, 9:20 http://www.biomedcentral.com/1472-6963/9/20
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